Efavirenz-Induced Decrease in Plasma Amprenavir Levels in Human Immunodeficiency Virus-Infected Patients and Correction by Ritonavir

Benzer Materyaller

• Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with Ritonavir
  Yazar:: Duval, Xavier, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
  Yazar:: Marcelin, Anne-Geneviève, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Kinetics of Antiviral Activity and Intracellular Pharmacokinetics of Human Immunodeficiency Virus Type 1 Protease Inhibitors in Tissue Culture
  Yazar:: Nascimbeni, Michelina, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Amprenavir and Efavirenz Pharmacokinetics before and after the Addition of Nelfinavir, Indinavir, Ritonavir, or Saquinavir in Seronegative Individuals
  Yazar:: Morse, Gene D., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients
  Yazar:: Goujard, Cecile, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)